The Quiet Giant: How Johnson & Johnson's Prescription Business Is Rewriting Its Growth Narrative Johnson & Johnson has long been a household name synonymous with consumer staples like Tylenol and Band Aid.
However, beneath its familiar surface lies a prescription business that is quietly transforming into a growth machine.
The oncology arm of J&J's prescription business is driving global sales growth, with its cancer fighting Darzalex leading the charge.